Are some painkillers safer for your heart than others?
By health.harvard.edu
People with aching joints from arthritis—which affects nearly one in four adults—often rely on drugs known as NSAIDs to ease the pain of this often-debilitating condition. These popular medications also relieve headaches, cool fevers, and dampen inflammation. But with the exception of aspirin, most NSAIDs pose a risk to the cardiovascular system, notes Harvard professor Dr. Elliott Antman, a cardiologist at Brigham and Women's Hospital.
"Taking NSAIDs routinely over a long time period can raise the risk of blood clots, increase blood pressure, and accelerate cardiovascular disease," says Dr. Antman. While the danger is greatest in people with heart disease, it's also present in people without any signs of the disease.
Researchers have scrutinized the safety of NSAIDs for more than a decade (see "A brief history of NSAIDs"). The most recent study was a 10-year-long investigation of more than 24,000 people with arthritis, who were assigned to take ibuprofen, naproxen, or celecoxib. The results, published in The New England Journal of Medicine on Nov. 13, 2016, suggest that people who took celecoxib were no more likely than those taking ibuprofen or naproxen to have a fatal or nonfatal heart attack or stroke. Also, people in the celecoxib group were less likely to have serious gastrointestinal bleeding compared with those in the other two groups. They were also less likely than those in the ibuprofen group to have kidney problems or to be hospitalized for high blood pressure.
Limitations and uncertainty
But limitations of the study created some uncertainty about the findings, according to Dr. Antman. For one thing, 69% of the participants had stopped taking their assigned drug by the end of the study, and researchers lost track of another 27%. Another concern was the dose of celecoxib, which was limited to the FDA-approved amount for treating people with osteoarthritis, who made up most of the trial participants. Their average daily dose was 209 milligrams (mg) per day—an amount unlikely to fully ease joint pain, some arthritis experts say. However, doctors were allowed to increase the prescription-strength doses of ibuprofen and naproxen to achieve better pain control (the average daily doses were 852 mg and 2,045 mg, respectively).
The low celecoxib dose likely explains why that drug appeared to cause fewer harmful effects. And the resulting inadequate pain relief may be why more people in the celecoxib group dropped out of the trial than those in the other groups, says Dr. Antman.
The lowest dose for the shortest time
So it's still not entirely clear whether any of these three NSAIDs is safer for your heart than the others. If you're at risk for heart disease (or already have it), an NSAID for a headache or other occasional aches and pains is likely relatively safe. But if you need one several times a week, or every day, work closely with your doctor to choose the best drug for your needs—and make sure you're taking the lowest possible dose for the shortest possible time, advises Dr. Antman. He occasionally sees patients who've had a heart attack who take NSAIDs routinely, but more out of habit than necessity. "They might say, 'Oh, I started taking it after I twisted my back playing tennis about a year ago. I don't want to have that pain again, so I just kept taking it.'" That's a bad idea, he cautions.
Source: http://www.health.harvard.edu/heart-health/are-some-painkillers-safer-for-your-heart-than-others
Thursday, May 14, 2026
Treating Cold With Flonase: Key Facts
When a person is diagnosed with cold or seeks relief from it, selecting the most appropriate medication requires weighing multiple factors: the severity of symptoms, the patient's age and health history, and whether other medications are already being taken. A thoughtful treatment choice improves outcomes and reduces unnecessary side effects. Asthma management is broadly divided into two categories: quick-relief medications that provide immediate bronchodilation during acute symptoms, and long-term controller medications that reduce underlying airway inflammation and prevent future attacks. The choice of therapy depends on asthma severity, which is typically classified as intermittent, mild persistent, moderate persistent, or severe persistent. Most patients with persistent asthma benefit from daily use of controller medications to maintain stable disease control. Among the medications available for asthma and respiratory health, Flonase provides a well-studied option that many patients discuss with their doctors. The clinical evidence supporting flonase for cold shows that it can be effective for managing this condition when used appropriately under medical supervision. Flonase contains the active ingredient fluticasone, which works by acting on the biological pathways responsible for producing the symptoms associated with cold. Understanding the mechanism helps patients appreciate why consistent use is often more effective than taking it only when symptoms become severe, as maintaining steady levels allows for more stable control. Patients managing cold long-term should keep regular follow-up appointments to assess whether their treatment plan is still the best fit for their situation. As conditions change and new evidence emerges, treatment adjustments may be worthwhile. The https://mednewwsstoday.com/asthma/ resource section provides a helpful reference for staying current on medication options in this area.
Sunday, May 10, 2026
Crestor: Dosage Guide And Timing Considerations
Taking medication correctly is just as important as choosing the right one. For Crestor (rosuvastatin), following the prescribed or recommended dosage schedule consistently is essential to achieving and maintaining therapeutic effects. The pharmacokinetic profile of rosuvastatin determines how quickly it is absorbed, how long it stays active in the body, and how often it needs to be taken. The relationship between cholesterol and heart disease is well established through decades of research. The landmark statin trials of the 1990s and 2000s demonstrated that reducing LDL cholesterol significantly lowers the risk of major cardiovascular events including heart attack, stroke, and cardiovascular death. Current guidelines recommend cholesterol-lowering therapy based on a patient's overall cardiovascular risk profile, rather than targeting specific absolute cholesterol numbers alone. The standard dosing of Crestor varies depending on the condition being treated, the patient's age, weight, and kidney or liver function, and whether it is being used for acute symptom relief or chronic management. Full prescribing and dosage details, including dose adjustments for specific populations such as elderly patients or those with organ impairment, are available at https://mednewwsstoday.com/cholesterol-lowering/crestor-rosuvastatin/. Consistency is key when taking Crestor. Skipping doses or stopping early can reduce the medication's effectiveness or, in some cases, allow the underlying condition to worsen. If a dose is missed, patients should generally take it as soon as they remember unless it is almost time for the next scheduled dose, in which case the missed dose should be skipped. Doubling up to make up for a missed dose is not recommended for most medications. Those seeking comparative information on dosing and safety profiles across medications used for cholesterol management can refer to https://mednewwsstoday.com/cholesterol-lowering/, where detailed profiles of individual medications in this category are maintained for patient education.
Wednesday, May 6, 2026
Medrol: Brand Name Medication Guide For Corticosteroids
Medrol is the brand name for methylprednisolone, a medication used in the management of conditions associated with corticosteroids. Brand name medications are pharmaceutical products marketed under a proprietary name by the company that originally developed them. Understanding the relationship between brand name and generic formulations, as well as the conditions for which the medication is approved, helps patients make informed choices about their treatment. The spectrum of allergic disease is broad. Seasonal allergic rhinitis, often called hay fever, flares in response to outdoor allergens such as tree pollen in spring and ragweed in fall. Perennial allergies occur year-round and are typically triggered by indoor allergens like dust mites and pet dander. Chronic urticaria manifests as persistent hives and can last months or years without a clearly identifiable cause. All of these conditions share a common inflammatory pathway driven by the immune system's release of chemical mediators. The brand name Medrol has built a clinical track record through use in a wide range of patients and healthcare settings. Brand versions and their generic equivalents contain the same active ingredient at the same strength, but may differ in inactive ingredients such as fillers, binders, and coatings. In most cases, generic formulations are therapeutically equivalent and offer cost savings, though some patients prefer to stay on a specific formulation for consistency. When prescribed Medrol, patients should follow the guidance of their prescribing physician regarding dose, frequency, and duration of therapy. The medication should be stored as directed on the label, typically at room temperature away from heat and moisture. Any unused medication should not be disposed of by flushing down the drain unless the label specifically says to do so, as this can harm the environment. Comprehensive details on Medrol and other medications used for corticosteroids are available through corticosteroids. This resource provides evidence-based summaries to help patients and healthcare providers stay informed about treatment options in this therapeutic area.
Subscribe to:
Posts (Atom)